Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03190863
Other study ID # 69HCL17_0016
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 29, 2018
Est. completion date May 29, 2025

Study information

Verified date September 2023
Source Hospices Civils de Lyon
Contact Sébastien MATEO, PhD
Phone 478 865 066
Email sebastien.mateo@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Motor imagery has shown promising results to optimize tenodesis grasp in individuals with C6-C7 tetraplegia. However, efficacy of using motor imagery to improve grasping after tetraplegia requires further study with higher level of evidence. In addition, controlling covert practice remains difficult due to the absence of overt movements. However, similar brain activity measured during both over and cover movements makes possible to provide visual information about the covert practice performance using neurofeedback. The Investigators thus designed this multicentric randomized controlled trial to investigate the effect of motor imagery with or with no visual neurofeedback on grasping capabilities after C6-C7 tetraplegia. They hypothesized that providing neurofeedback based on brain activity measured by electroencephalography namely knowing the covert practice performance would results in greater grasping improvement in response to practice as compared to motor imagery practice alone.


Recruitment information / eligibility

Status Recruiting
Enrollment 21
Est. completion date May 29, 2025
Est. primary completion date May 29, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Volunteer individuals with C6-C7 tetraplegia with complete finger flexor paralysis restricting grasping capabilities to the tenodesis. - Consent to participate to the study after receiving clear, loyal and appropriate information. - Aged between 18 and 55 years. - Time since spinal cord injury above 6 months - Stabilized condition in particular sensori-motor deficit. - Sitting position for more than 1 hour - Able to imagine movement - Health care beneficiary Exclusion Criteria: - Long-lasting autonomic disorders while sitting (orthostatic hypotension and/or blood pressure instability) limiting sitting position to less than 1 hour. - Upper limb pain for either mechanic or neuropathic reasons preventing all grasping movement and/or the ability to imagine those movements. - Restricted wrist and finger range of motion preventing the tenodesis grasp. - Patient after surgical tendon transfer that improved grasping capabilities (e.g. active finger flexion). - Ongoing participation in another research that aim to evaluate an intervention likely to improve the neurological or functional recovery introducing an experimental bias. - Specific contraindication to Magnetoencephalography with the presence of metallic fragments inside the body such as pace-maker, neurostimulator, cochlear implants, steel dental implant and osteosynthesis material only applicable to the participants included in Lyon hospital center (n=15).

Study Design


Related Conditions & MeSH terms

  • Individuals With C6-C7 Tetraplegia (AIS A or B)
  • Quadriplegia

Intervention

Behavioral:
Motor imagery combined with neurofeedback (MINF)
7 individuals with C6-C7 tetraplegia randomize in the experimental group consisting in motor imagery practice combined with visual neurofeedback (NF - i.e. performance of the imagined movement). Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions. After each imagined movement, the NF based on brain activity measured by electroencephalography is display on a screen.
Motor imagery (MI)
7 individuals with C6-C7 tetraplegia randomized in the active comparator group consisting in motor imagery practice alone without visual NF. This means that the performance of the imagined movement is not displayed to the participants. Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions.
Control (C)
7 individuals with C6-C7 tetraplegia randomized in the sham comparator group consisting in imagining geometric shapes by visualization. Shapes are successively displayed on a screen. Intervention consists in a total of 15 sessions repeated 3 times a week and lasting 5 weeks. Each session will last 45 minutes. An experienced physical therapist supervised all sessions.

Locations

Country Name City State
France Le Centre Mutualiste Neurologique PROPARA, Parc Euromédecine Montpellier
France Service de médecine physique et de réadaptation, Hôpital Henry Gabrielle Saint-Genis-Laval

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

References & Publications (1)

Mateo S, Di Rienzo F, Reilly KT, Revol P, Delpuech C, Daligault S, Guillot A, Jacquin-Courtois S, Luaute J, Rossetti Y, Collet C, Rode G. Improvement of grasping after motor imagery in C6-C7 tetraplegia: A kinematic and MEG pilot study. Restor Neurol Neurosci. 2015;33(4):543-55. doi: 10.3233/RNN-140466. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Wrist extension angle in degree during grasping with 3D motion analysis system Individuals with C6-C7 tetraplegia extend their wrist to grasp using tenodesis. Specifically, the wrist extension shortens the tendons of fingers and thumbs flexors that elicit either a palmar or a lateral grip. A complete reach-to-grasp movement will be recorded using a 3D motion analysis system (Vicon Motion Systems Ltd. UK). Wrist extension angle in degree will be measure during grasping when the object is grasped. Up to 19 weeks
Secondary Temporal kinematic parameters of reach-to-grasp movements with 3D motion analysis system (Vicon Motion Systems Ltd. UK). Computation of temporal kinematic parameters (e.g. movement duration) measured during a complete reach-to-grasp movement using a 3D motion analysis system (Vicon Motion Systems Ltd. UK). Temporal parameters are also aggregated with spatial parameters. Up to 19 weeks
Secondary Spatial kinematic parameters of reach-to-grasp movements with 3D motion analysis system (Vicon Motion Systems Ltd. UK). Computation of spatial kinematic parameters (e.g. movement trajectory) measured during a complete reach-to-grasp movement using a 3D motion analysis system (Vicon Motion Systems Ltd. UK).Spatial parameters are also aggregated with temporal parameters. Up to 19 weeks
Secondary Brain activity change in response to intervention using magnetoencephalography Brain activity will be measured during upper limb movement (e.g. a complete reach-to-grasp movement) using magnetoencephalography. The device is only available in Lyon Hospital. Correspondingly, fifteen participants included in Lyon Hospital will achieve this measure. Up to 19 weeks
Secondary passive upper limb range of motion (ROM) measured using goniometer and/or inclinometer This outcome will be measured using goniometer and/or inclinometer by the same blind and experienced physical therapist Up to 19 weeks
Secondary Upper limb strength measured using the hand held dynamometer This outcome will be measured using the manual muscle test and the hand held dynamometer by the same blind and experienced physical therapist. Up to 19 weeks
Secondary Upper limb strength measured using the manual muscle test This outcome will be measured using the manual muscle test and the hand held dynamometer by the same blind and experienced physical therapist. Up to 19 weeks
Secondary Hand dexterity measured using the Box and Block test This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist Up to 19 weeks
Secondary Hand dexterity measured using the Nine Hole Peg test This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist Up to 19 weeks
Secondary Hand dexterity measured using the Jebsen test This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist Up to 19 weeks
Secondary Hand dexterity measured using the Capability of Upper Limb test This outcome will be measured using i) the Box and Block Test, ii) the Nine Hole Peg Test, iii) the Jebsen Test and iv) the Capability of Upper Limb Test supervised by the same blind and experienced occupational therapist Up to 19 weeks
Secondary Quality of Life measured using the WHOQOL-Bref This outcome will be measured using the WHOQOL-Bref by the same blind and experienced physical therapist. Up to 19 weeks
Secondary Daily life autonomy measured using the Quadriplegic Index of Function This outcome will be measured using the Quadriplegic Index of Function by the same blind and experienced physical therapist. Up to 19 weeks
Secondary Motor imagery capability measured by the Kinesthetic Visual Imagery Questionnaire Motor imagery capability will be measured by the Kinesthetic Visual Imagery Questionnaire by the same blind and experienced physical therapist along with comparing overt and covert movement duration, galvanic skin response, electroencephalography activity. Up to 19 weeks

External Links